https://www.selleckchem.com/pr....oducts/ide397-gsk-43
redictors for symptomatically suspected COVID-19 cases. There was no association between incidence of COVID-19 and use of reflux medications, including famotidine at doses used orally to manage reflux and high dose PPIs. Reflux medications did not protect against or increase the risk of COVID-19. There was no association between incidence of COVID-19 and use of reflux medications, including famotidine at doses used orally to manage reflux and high dose PPIs. Reflux medications did not protect against or increase the risk of C
Like
Comment
Share
